Mitral valve replacement with the pulmonary autograft: Ross II procedure with Kabanni modification.
We report our experience with pulmonary autograft replacement of the mitral valve in eight patients. Hospital mortality of 0% was reported, and there has been one autograft failure requiring replacement (mean follow-up 12 +/- 6 months). We also review the world's experience with this technique. Mitral valve replacement with a pulmonary autograft (Ross II) is safe, reproducible, and possible warranted for selected patients.
Brown
John W
JW
Department of Surgery, Indiana University School of Medicine, Indianapolis 46202, USA.
Ruzmetov
Mark
M
Turrentine
Mark W
MW
Rodefeld
Mark D
MD
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008297:Male; D008944:Mitral Valve Insufficiency / Q000601:surgery*; D008946:Mitral Valve Stenosis / Q000601:surgery*; D011651:Pulmonary Artery / Q000637:transplantation*; D014182:Transplantation, Autologous / Q000379:methods; D016896:Treatment Outcome